Yes, GDNFs can serve as potential biomarkers for certain cancers. Elevated levels of GDNF in bodily fluids or tumor tissues may indicate tumor presence, progression, or response to therapy. For example, higher serum levels of GDNF have been observed in patients with metastatic breast cancer compared to those with localized disease.
